Product claims are one of the most sensitive regulatory elements in healthcare-related products. Whether pharmaceutical, cosmetic, or medical device, the wording used on labels, packaging, promotional materials, and advertisements directly impacts product classification, approval pathways, and legal exposure. The Egyptian Drug Authority (EDA) Claim Guideline establishes a clear regulatory framework governing acceptable and unacceptable claims within the Egyptian market. This article explores the regulatory foundations of product claims and what manufacturers must understand before entering the Egyptian market.
What Is a “Claim”?
A claim is any statement, representation, or implication regarding a product’s:
Under EDA rules, all claims must be
Consistent with product classification
Supported by documented evidence
Why Claims Matter in Regulatory Classification
A single claim can change the regulatory category of a product.
A cosmetic claiming “moisturizes skin” may remain cosmetic.
The same product claiming “treats eczema” may be classified as a pharmaceutical product.
Key Regulatory Principles from the Guideline
1- Claims must be truthful and not misleading.
2- Claims must be supported by scientific evidence.
3- Claims must not exaggerate product capabilities.
4- Claims must align with approved indications.
5- Comparative claims must be evidence-based and fair.
Regulatory Risk for Manufacturers
Non-compliant claims may result in:
This makes internal claim review procedures essential.
Key Takeaway
The EDA Claim Guideline reinforces that regulatory compliance does not stop at product approval – it extends into marketing communication. A structured claim review process is now a necessity for companies operating in Egypt. Proactive compliance protects both brand and long-term market access.
